PAVmed (NASDAQ: PAVM)
$0.43
(-3.6%)
-$0.02
Price as of September 30, 2025, 3:59 p.m. ET
PAVmed Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
PAVmed Company Info
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY.
News & Analysis
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.